High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda-Reference-Cited by-同舟云学术

High Acceptability and Perceived Feasibility of Long-Acting Injectable Antiretroviral Treatment Among People Living with HIV Who Are Viremic and Health Workers in Uganda

Published:2023-06-01 Issue:6 Volume:37 Page:316-322
ISSN:1087-2914
Container-title:AIDS Patient Care and STDs
language:en
Short-container-title:AIDS Patient Care and STDs

Author:

Kennedy Caitlin E.¹^ORCID,Zhao Tongying¹,Vo Anh Van¹,Nakubulwa Rosette²,Nabakka Proscovia²,Jackson Jade³,Rosen Joseph G.¹^ORCID,Chang Larry W.¹⁴,Reynolds Steven J.⁴⁵,Quinn Thomas C.⁵,Nakigozi Gertrude²,Kigozi Godfrey²,Kagaayi Joseph²,Nalugoda Fred²,Ddaaki William G.²,Grabowski M. Kate³,Nakyanjo Neema²

Affiliation:

1. Department of International Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.

2. Rakai Health Sciences Program, Kalisizo, Uganda.

3. Department of Pathology and School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

4. Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

5. Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, US National Institutes of Health, Bethesda, Maryland, USA.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://www.liebertpub.com/doi/pdf/10.1089/apc.2023.0017

Reference27 articles.

1. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

2. The potential role of long-acting injectable cabotegravir–rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis

3. Realizing the promise of long-acting antiretroviral treatment strategies for individuals with HIV and adherence challenges: an illustrative case series

4. First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV Clinic

5. A new paradigm for antiretroviral delivery: long-acting cabotegravir and rilpivirine for the treatment and prevention of HIV

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-acting injectable antiretroviral treatment: experiences of people with HIV and their healthcare providers in Uganda;BMC Infectious Diseases;2024-08-28

2. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain;AIDS Patient Care and STDs;2024-07-01

3. Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York;JMIR Research Protocols;2024-03-27

4. Long-Acting Injectable Antiretrovirals for HIV Treatment: A Multi-Site Qualitative Study of Clinic-Level Barriers to Implementation in the United States;AIDS Patient Care and STDs;2024-02-01

5. Patient Education and Decision Support for Long-Acting Injectable HIV Antiretroviral Therapy: Protocol for Tool Development and Pilot Testing with Ryan White HIV/AIDS Program Medical Case Management Programs in New York (Preprint);2024-01-29